Technology areas: Biotechnology & Pharmaceuticals • Transportation, E-Commerce & Mechanical Systems
6 pending office actions • 5 clients • 6 examiners • 6 art units • 0 of 6 (0%) have an AI response strategy ready
CredIPR LLC operates in Biotechnology & Pharmaceuticals. Its profile includes 5 pending office actions and 78 career applications, reflecting a small active docket and a limited historical application record.
The resolved allowance rate is 80.0%, while the average is 2.13 office actions per allowance. The data indicates that resolved matters frequently reach allowance after relatively few examination exchanges. Practitioners should nevertheless review the individual scientific disclosures and cited references before applying this portfolio-level pattern to a pending case.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (33%) |
| §103 only | 1 (17%) |
| Multi-statute (no §101) | 3 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WALSH, EMMETT K | 1 | 52.5% | +20.1% |
| GOMEZ, CHRISTOPHER ALBERT | 1 | 26.4% | +30.9% |
| PIERORAZIO, JILLIAN KUTCH | 1 | 59.3% | +32.1% |
| DUFFY, PATRICIA ANN | 1 | 52.9% | +33.9% |
| STAVROU, CONSTANTINA E | 1 | 42.4% | +35.6% |
| MORNHINWEG, JEFFREY P | 1 | 36.7% | +32.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19146928 | TELEX MESSAGE PROCESSING METHOD AND APPARATUS, ELECTRONIC DEVICE, AND COMPUTER STORAGE MEDIUM | WALSH, EMMETT K | — |
| 19146925 | AIRLINE TICKET CHANGE INFORMATION PROCESSING METHOD AND APPARATUS, AND ELECTRONIC DEVICE AND STORAGE MEDIUM | GOMEZ, CHRISTOPHER ALBERT | — |
| 18995937 | PROCESS FOR PRODUCTION OF A MULTILAYER CLOTH PRODUCT | PIERORAZIO, JILLIAN KUTCH | — |
| 18993591 | L-HOMOSERINE HIGH-YIELD STRAIN, CONSTRUCTION METHOD THEREFOR, AND USE THEREOF | DUFFY, PATRICIA ANN | — |
| 18793848 | COMPOSITIONS FOR USE IN THE TREATMENT OF MUSCULOSKELETAL CONDITIONS AND METHODS FOR PRODUCING THE SAME LEVERAGING THE SYNERGISTIC ACTIVITY OF TWO DIFFERENT TYPES OF MESENCHYMAL STROMAL/STEM CELLS | STAVROU, CONSTANTINA E | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19146928 | TELEX MESSAGE PROCESSING METHOD AND APPARATUS, ELECTRONIC DEVICE, AND COMPUTER STORAGE MEDIUM | WALSH, EMMETT K | — |
| 19146925 | AIRLINE TICKET CHANGE INFORMATION PROCESSING METHOD AND APPARATUS, AND ELECTRONIC DEVICE AND STORAGE MEDIUM | GOMEZ, CHRISTOPHER ALBERT | — |
| 18995937 | PROCESS FOR PRODUCTION OF A MULTILAYER CLOTH PRODUCT | PIERORAZIO, JILLIAN KUTCH | — |
| 18993591 | L-HOMOSERINE HIGH-YIELD STRAIN, CONSTRUCTION METHOD THEREFOR, AND USE THEREOF | DUFFY, PATRICIA ANN | — |
| 18793848 | COMPOSITIONS FOR USE IN THE TREATMENT OF MUSCULOSKELETAL CONDITIONS AND METHODS FOR PRODUCING THE SAME LEVERAGING THE SYNERGISTIC ACTIVITY OF TWO DIFFERENT TYPES OF MESENCHYMAL STROMAL/STEM CELLS | STAVROU, CONSTANTINA E | — |
| 17046782 | BLOOD-FREE DIET FOR REARING MALARIA MOSQUITO VECTORS | MORNHINWEG, JEFFREY P | — |
| Client (Assignee) | Pending OAs |
|---|---|
| TRAVELSKY TECHNOLOGY LIMITED | 2 |
| DR. SCHUMACHER | 1 |
| Nanjing Shengde Biotech Co., Ltd. | 1 |
| Regenera Sciences Ip, Lda. | 1 |
| Centro De Ciencias Do Mar Do Algarve | 1 |
| Art Unit | Apps |
|---|---|
| 3626 | 1 |
| 3628 | 1 |
| 3732 | 1 |
| 1645 | 1 |
| 1632 | 1 |
| 1793 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19146928 | TELEX MESSAGE PROCESSING METHOD AND APPARATUS, ELECTRONIC DEVICE, AND COMPUTER STORAGE MEDIUM | Travelsky Technology Limited | WALSH, EMMETT K | 3626 | §101§103 | Non-Final OA | — | Pending | Jul 10, 2025 |
| 19146925 | AIRLINE TICKET CHANGE INFORMATION PROCESSING METHOD AND APPARATUS, AND ELECTRONIC DEVICE AND STORAGE MEDIUM | Travelsky Technology Limited | GOMEZ, CHRISTOPHER ALBERT | 3628 | §101§112 | Final Rejection | — | Pending | Jul 10, 2025 |
| 18995937 | PROCESS FOR PRODUCTION OF A MULTILAYER CLOTH PRODUCT | Dr. Schumacher GmbH | PIERORAZIO, JILLIAN KUTCH | 3732 | §103§112 | Non-Final OA | — | Pending | Jan 17, 2025 |
| 18993591 | L-HOMOSERINE HIGH-YIELD STRAIN, CONSTRUCTION METHOD THEREFOR, AND USE THEREOF | Nanjing Shengde Biotech Co., Ltd. | DUFFY, PATRICIA ANN | 1645 | §103§112 | Non-Final OA | — | Pending | Jan 13, 2025 |
| 18793848 | COMPOSITIONS FOR USE IN THE TREATMENT OF MUSCULOSKELETAL CONDITIONS AND METHODS FOR PRODUCING THE SAME LEVERAGING THE SYNERGISTIC ACTIVITY OF TWO DIFFERENT TYPES OF MESENCHYMAL STROMAL/STEM CELLS | Regenera Sciences Ip, Lda. | STAVROU, CONSTANTINA E | 1632 | §103§112 | Non-Final OA | — | Pending | Aug 04, 2024 |
| 17046782 | BLOOD-FREE DIET FOR REARING MALARIA MOSQUITO VECTORS | Centro De Ciencias Do Mar Do Algarve | MORNHINWEG, JEFFREY P | 1793 | §103 | Final Rejection | — | Pending | Oct 11, 2020 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial80.0% of resolved applications prosecuted by Credipr LLC were allowed, across 78 applications in USPTO records.
2.13 office actions per allowed application on average.
6 pending office actions as of October 2026, for 5 clients, before 6 examiners in 6 art units.
